← companiesMRNA · Moderna
Moderna
Next report: Q3 2026, 6 November before the open.
MRNAModernareports 6 NovQuarter forecast · Q3 2026→$0.85B sales
−$1.10 diluted EPSfree, line by line, 5 analystsHow the company works→What it sells, how it makes money, and the anatomy of the extremes.
−$1.10 diluted EPSfree, line by line, 5 analysts
Release reviewThe first one comes after the Q3 2026 report on 6 November.
For subscribers
After the callAfter the Q3 2026 call.
Full forecast→Sales for every quarter and year ahead, line by line.Report daysnewest first
Q3 20266 November 2026